Autism’s Medicare and Medicare Approaches, Revisited

Bahram Alamdary Badlou

PhD Hematology, BBAdvies and Research, Research and Development Dept. Zeist, The Netherlands

Dr. Bahram Alamdary Badlou, PhD Hematology, BBAdvies and Research, Research and Development dept. Zeist, The Netherlands.

Keywords: Autism; Metabolic Disease; Sensory Disorder; Hematology; Human

Abstract

Autisms has different types and is an distressing diseases with still unknown standard cure, which affect both patient and their family lifestyle, significantly.
Momeni N., et al. 2012 [1] revealed main hematologic changes, which disentangle how Medici can diagnose Autism in an easy manner, who are suffering from sensory processing disorders (SPD). Although, Autism is a SPD disorder but eventually was correlated with systemic blood circulation changes i.e. an increase in dysfunctional (un-)known proteins and peptides depending on Autism-Blood Circulating Factor (ABCF), however. Up to date (2021), another kinds of Autism, which are Autism Non-Blood Circulating Factors (ANBFs), which are still little known about them, and these ANBFs’ diagnostics and treatments is also not elucidated completely.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).